Amersham Amerlex (9221)
Specialty: General Immunology
Welcome to the PulseAid listing for the Amersham Amerlex medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Alpha-fetoprotein – tumor marker (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Alpha-fetoprotein, amniotic fluid (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Alpha-fetoprotein, maternal serum (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Cortisol (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Estriol, total (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Estriol, unconjugated (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
| Ferritin (CDC000015 | CDC000015) | HIGH Effective Date: 1993-07-26 |
Other Amersham Amerlex Medical Devices:
| Medical Device | Complexity |
| Amersham Amerlex-M (9223) hCG, beta, serum, quantitative | Thyroxine, free (FT4) | Triiodothyronine (T3) | Triiodothyronine, free (FT3) | | View Complexity |